Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Norden Group LLC

Norden Group LLC reduced its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 34.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,973 shares of the company's stock after selling 14,514 shares during the quarter. Norden Group LLC's holdings in Ryan Specialty were worth $1,795,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC acquired a new position in Ryan Specialty during the third quarter worth $753,000. State of Alaska Department of Revenue increased its position in shares of Ryan Specialty by 7.2% in the third quarter. State of Alaska Department of Revenue now owns 11,940 shares of the company's stock valued at $792,000 after buying an additional 805 shares in the last quarter. Stephens Inc. AR acquired a new stake in Ryan Specialty in the 3rd quarter valued at about $289,000. Janney Montgomery Scott LLC increased its holdings in Ryan Specialty by 11.8% during the 3rd quarter. Janney Montgomery Scott LLC now owns 16,994 shares of the company's stock valued at $1,128,000 after acquiring an additional 1,799 shares in the last quarter. Finally, Geneva Partners LLC acquired a new position in Ryan Specialty during the third quarter worth about $2,537,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Trading Up 1.1 %

Ryan Specialty stock traded up $0.79 during midday trading on Wednesday, reaching $70.77. The stock had a trading volume of 768,515 shares, compared to its average volume of 996,386. The stock's 50-day simple moving average is $66.24 and its 200 day simple moving average is $67.50. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market capitalization of $18.53 billion, a PE ratio of 102.56, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72.

Remove Ads

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be paid a dividend of $0.12 per share. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, March 4th. Ryan Specialty's payout ratio is currently 69.57%.

Insider Transactions at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00. Following the completion of the sale, the director now owns 60,200 shares of the company's stock, valued at $4,015,942. This represents a 36.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 316,451 shares of company stock valued at $20,907,793 over the last 90 days. Corporate insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of recent research reports. Royal Bank of Canada reduced their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. Wells Fargo & Company lifted their price objective on Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a report on Friday, February 21st. Barclays boosted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research report on Thursday, November 21st. Finally, Morgan Stanley initiated coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an "overweight" rating and a $90.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $75.27.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.